跳至主要内容
临床试验/NCT05175807
NCT05175807Unknown不适用

Application of a Telemedicine Brief Mindfulness Intervention in Post-COVID-19: a Pilot Randomized and Controlled Trial

Fondazione Don Carlo Gnocchi Onlus1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2020年6月19日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
40
试验地点
1
主要终点
Symptoms of Post-Traumatic Stress Disorder (PTSD)

研究概览

简要总结

Background: Several studies suggest that SARS survivors still presented with high levels of psychological distress overall at 1, 3, 12, and 18 months after hospital discharge. Nonetheless, there are no data available in the literature regarding the implementation of interventions that are psychological interventions, let alone specific ones. In particular, the practice of mindfulness, formalized in the protocols such as Mindfulness Based Stress Reduction (MBSR) and Mindfulness Based Cognitive Therapy (MBCT). Based Cognitive Therapy (MBCT), have proved to be very effective in reducing stress related to chronic conditions and of depression. However, these protocols typically require a high level of engagement for participants, which is why, in the present exploratory study, the investigators opted to evaluate the implementation of a Mindfulness-based protocol that is short and less intense, but which has shown good results on health-related outcomes, even with a single session.

Objectives: In this perspective, it becomes important to detect the presence of psychological distress in those who have contracted COVID-19 and are now undertaking a rehabilitation program, from the perspective of promoting well-being and prevention of possible aggravation if not prolongation of mental suffering in the long term.

Study Design: Randomized and Controlled (RCT), two-arm pilot study with three data captures (baseline=T0, 3 weeks=T1, 3 months=T2).

Participants: People who have previously tested positive for COVID-19, now negative and hospitalized at the IRCCS Santa Maria Nascente of the Fondazione Don Carlo Gnocchi in Milan.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Previously positive for COVID-19 and now negative and undergoing treatment Pulmonary rehabilitation;
  • •Compatibility to participate in the study as judged by the physician;
  • •Able to provide Informed Consent.

排除标准

  • •The physician's unfavorable opinion of inclusion in the study because he or she is unable to provide Informed Consent;
  • •Patients with lung cancer;
  • •Documented psychiatric disorders;
  • •Immunodepression;
  • •Patients with terminal or neurodegenerative diseases (e.g., other forms of cancer, Amyotrophic Lateral Sclerosis (ALS)).

研究组 & 干预措施

Mindfulness Group_1

Experimental

The intervention will be characterized by be based on Mindfulness exercises (e.g. body scan, gentle yoga, sitting, grounding and walking meditation), relaxation techniques and cognitive rehabilitation exercises. walking), relaxation techniques and cognitive rehabilitation exercises. The objective is to provide specific practical skills to learn how to deal with difficult and/or stressful situations managing emotions and intercurrent thoughts. The intervention is proposed to last for a total of 5-6 sessions lasting 45 minutes each, two sessions per week, for a three-week commitment. In addition, between sessions, reflection materials, readings or exercises will be offered. The intervention will be conducted in telemedicine by a Psychologist, who has experience in conducting these interventions and who receives regular supervision. The sessions will be conducted through special platform and audio-recorded to ensure the reliability of the data collected, prior consent.

干预措施: Mindfulness (Other)

Waiting List Group_2

No Intervention

In both groups the "usual care" or usual treatment, will consist of the usual daily medical examinations of the department, respiratory and motor physiotherapy sessions. The Group 2, therefore, will not be submitted to other type of treatment outside of that previewed near O.U. for the course of the first three weeks, during which they will be placed on the waiting list. Once the Once the assessment is carried out after 3 weeks, we will proceed to implement the intervention proposed to the Group 1. If the participant has already been discharged from the structure, it will still be possible to proceed with the intervention, since it is online. If the participant has already been discharged from the structure, you can still proceed with the intervention, since this is in telemedicine, in order to promote the continuity hospital-territory.

结局指标

主要结局

Symptoms of Post-Traumatic Stress Disorder (PTSD)

时间窗: Change from baseline at 3 weeks and at 3 months

Symptoms of Post-Traumatic Stress Disorder (PTSD) as measured by the Impact of Event Scale (IES) (Horowitz, Wilner, \& Alvarez, 1979). The revised version of the Impact of Event Scale (IES-r) has seven additional questions and a scoring range of 0 to 88. On this test, scores that exceed 24 can be quite meaningful. High scores have the following associations.

次要结局

  • Depression(Change from baseline at 3 weeks and at 3 months)
  • Changes with respect to respiratory function(Change from baseline at 3 weeks and at 3 months)
  • Changes in arterial blood gas analysis (ABG)(Change from baseline at 3 weeks and at 3 months)
  • CBC, basal cortisolemia ACTH, CPK(Change from baseline at 3 weeks and at 3 months)
  • Anxiety 2006), at baseline, 3 weeks, 3 months after recruitment.(Change from baseline at 3 weeks and at 3 months)
  • Psychological distress(Change from baseline at 3 weeks and at 3 months)
  • Counterfactual thinking and peritraumatic emotions of guilt, shame, and fear in relation to the events stressful events(Change from baseline at 3 weeks and at 3 months)
  • Changes in oxygen saturation (SpO2)(Change from baseline at 3 weeks and at 3 months)
  • Change in CBC, ferritin, fibrinogen, creatinine, electrolytes, transaminases, d-dimer values, immunoelectrophoresis, baseline cortisolemia ACTH, CPK, COVID-19-related serological values of IgG and IgM.(Change from baseline at 3 weeks and at 3 months)
  • Well-being(Change from baseline at 3 weeks and at 3 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Paolo Banfi

MD, Chief of the Cardio-Respiratory Rehabilitation

Fondazione Don Carlo Gnocchi Onlus

研究点 (1)

Loading locations...

相似试验